BR112023019999A2 - Métodos para depletar seletivamente fragmentos não desejáveis de bibliotecas amplificadas de dna ou cdna mediante o uso de um ou mais oligonucleotídeos bloqueadores e kits para a preparação de biblioteca baseada em rna-seq - Google Patents
Métodos para depletar seletivamente fragmentos não desejáveis de bibliotecas amplificadas de dna ou cdna mediante o uso de um ou mais oligonucleotídeos bloqueadores e kits para a preparação de biblioteca baseada em rna-seqInfo
- Publication number
- BR112023019999A2 BR112023019999A2 BR112023019999A BR112023019999A BR112023019999A2 BR 112023019999 A2 BR112023019999 A2 BR 112023019999A2 BR 112023019999 A BR112023019999 A BR 112023019999A BR 112023019999 A BR112023019999 A BR 112023019999A BR 112023019999 A2 BR112023019999 A2 BR 112023019999A2
- Authority
- BR
- Brazil
- Prior art keywords
- kits
- methods
- rna
- seq
- blocking oligonucleotides
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6844—Nucleic acid amplification reactions
- C12Q1/6848—Nucleic acid amplification reactions characterised by the means for preventing contamination or increasing the specificity or sensitivity of an amplification reaction
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/48—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving transferase
- C12Q1/485—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving transferase involving kinase
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6844—Nucleic acid amplification reactions
- C12Q1/6853—Nucleic acid amplification reactions using modified primers or templates
- C12Q1/6855—Ligating adaptors
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2525/00—Reactions involving modified oligonucleotides, nucleic acids, or nucleotides
- C12Q2525/10—Modifications characterised by
- C12Q2525/113—Modifications characterised by incorporating modified backbone
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2525/00—Reactions involving modified oligonucleotides, nucleic acids, or nucleotides
- C12Q2525/10—Modifications characterised by
- C12Q2525/117—Modifications characterised by incorporating modified base
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2525/00—Reactions involving modified oligonucleotides, nucleic acids, or nucleotides
- C12Q2525/10—Modifications characterised by
- C12Q2525/186—Modifications characterised by incorporating a non-extendable or blocking moiety
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2531/00—Reactions of nucleic acids characterised by
- C12Q2531/10—Reactions of nucleic acids characterised by the purpose being amplify/increase the copy number of target nucleic acid
- C12Q2531/113—PCR
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2537/00—Reactions characterised by the reaction format or use of a specific feature
- C12Q2537/10—Reactions characterised by the reaction format or use of a specific feature the purpose or use of
- C12Q2537/163—Reactions characterised by the reaction format or use of a specific feature the purpose or use of blocking probe
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Biophysics (AREA)
- Analytical Chemistry (AREA)
- Physics & Mathematics (AREA)
- Immunology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Saccharide Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163169185P | 2021-03-31 | 2021-03-31 | |
| PCT/US2022/022663 WO2022212589A1 (en) | 2021-03-31 | 2022-03-30 | Blocking oligonucleotides for the selective depletion of non-desirable fragments from amplified libraries |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BR112023019999A2 true BR112023019999A2 (pt) | 2023-11-14 |
Family
ID=81346581
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR112023019999A BR112023019999A2 (pt) | 2021-03-31 | 2022-03-30 | Métodos para depletar seletivamente fragmentos não desejáveis de bibliotecas amplificadas de dna ou cdna mediante o uso de um ou mais oligonucleotídeos bloqueadores e kits para a preparação de biblioteca baseada em rna-seq |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US20240191288A1 (https=) |
| EP (1) | EP4314335A1 (https=) |
| JP (1) | JP2024512463A (https=) |
| KR (1) | KR20230163386A (https=) |
| CN (1) | CN117098855A (https=) |
| AU (1) | AU2022252302A1 (https=) |
| BR (1) | BR112023019999A2 (https=) |
| CA (1) | CA3213037A1 (https=) |
| IL (1) | IL306060A (https=) |
| MX (1) | MX2023011523A (https=) |
| WO (1) | WO2022212589A1 (https=) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2024137316A1 (en) * | 2022-12-23 | 2024-06-27 | Foundation Medicine, Inc. | Oligonucleotides and methods for capturing single-stranded templates and/or templates with 3' overhangs |
| WO2024220771A1 (en) * | 2023-04-21 | 2024-10-24 | Ohio State Innovation Foundation | Rapid enzyme-free release of single-stranded dna from unmodified dsdna templates |
| WO2025244841A1 (en) | 2024-05-23 | 2025-11-27 | Illumina, Inc. | Methods and systems for quantifying targeted enrichment efficiency |
| CN120060439B (zh) * | 2025-02-27 | 2026-03-10 | 江苏硕世生物科技股份有限公司 | 一种基于封闭引物去人源核酸的测序文库构建方法及应用 |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4683195A (en) | 1986-01-30 | 1987-07-28 | Cetus Corporation | Process for amplifying, detecting, and/or-cloning nucleic acid sequences |
| US4683202A (en) | 1985-03-28 | 1987-07-28 | Cetus Corporation | Process for amplifying nucleic acid sequences |
| US5677170A (en) | 1994-03-02 | 1997-10-14 | The Johns Hopkins University | In vitro transposition of artificial transposons |
| US5681702A (en) | 1994-08-30 | 1997-10-28 | Chiron Corporation | Reduction of nonspecific hybridization by using novel base-pairing schemes |
| US5962271A (en) | 1996-01-03 | 1999-10-05 | Cloutech Laboratories, Inc. | Methods and compositions for generating full-length cDNA having arbitrary nucleotide sequence at the 3'-end |
| US5849497A (en) * | 1997-04-03 | 1998-12-15 | The Research Foundation Of State University Of New York | Specific inhibition of the polymerase chain reaction using a non-extendable oligonucleotide blocker |
| US6391592B1 (en) * | 2000-12-14 | 2002-05-21 | Affymetrix, Inc. | Blocker-aided target amplification of nucleic acids |
| JP5073967B2 (ja) | 2006-05-30 | 2012-11-14 | 株式会社日立製作所 | 単一細胞の遺伝子発現定量方法 |
| CA2877094A1 (en) * | 2012-06-18 | 2013-12-27 | Nugen Technologies, Inc. | Compositions and methods for negative selection of non-desired nucleic acid sequences |
| US20140274729A1 (en) * | 2013-03-15 | 2014-09-18 | Nugen Technologies, Inc. | Methods, compositions and kits for generation of stranded rna or dna libraries |
| WO2017142989A1 (en) * | 2016-02-17 | 2017-08-24 | Admera Health LLC | Nucleic acid preparation and analysis |
| CN110382708A (zh) * | 2017-02-01 | 2019-10-25 | 赛卢拉研究公司 | 使用阻断性寡核苷酸进行选择性扩增 |
| EP3622089B1 (en) * | 2017-05-08 | 2024-07-17 | Illumina, Inc. | Method for sequencing using universal short adapters for indexing of polynucleotide samples |
| WO2020068559A1 (en) * | 2018-09-25 | 2020-04-02 | Qiagen Sciences, Llc | Depleting unwanted rna species |
-
2022
- 2022-03-30 JP JP2023556903A patent/JP2024512463A/ja active Pending
- 2022-03-30 CA CA3213037A patent/CA3213037A1/en active Pending
- 2022-03-30 EP EP22718007.2A patent/EP4314335A1/en active Pending
- 2022-03-30 IL IL306060A patent/IL306060A/en unknown
- 2022-03-30 CN CN202280025253.7A patent/CN117098855A/zh active Pending
- 2022-03-30 US US18/285,222 patent/US20240191288A1/en active Pending
- 2022-03-30 AU AU2022252302A patent/AU2022252302A1/en not_active Abandoned
- 2022-03-30 BR BR112023019999A patent/BR112023019999A2/pt not_active Application Discontinuation
- 2022-03-30 WO PCT/US2022/022663 patent/WO2022212589A1/en not_active Ceased
- 2022-03-30 KR KR1020237032007A patent/KR20230163386A/ko active Pending
- 2022-03-30 MX MX2023011523A patent/MX2023011523A/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CN117098855A (zh) | 2023-11-21 |
| MX2023011523A (es) | 2023-10-06 |
| KR20230163386A (ko) | 2023-11-30 |
| WO2022212589A1 (en) | 2022-10-06 |
| EP4314335A1 (en) | 2024-02-07 |
| AU2022252302A1 (en) | 2023-09-14 |
| JP2024512463A (ja) | 2024-03-19 |
| CA3213037A1 (en) | 2022-10-06 |
| IL306060A (en) | 2023-11-01 |
| US20240191288A1 (en) | 2024-06-13 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR112023019999A2 (pt) | Métodos para depletar seletivamente fragmentos não desejáveis de bibliotecas amplificadas de dna ou cdna mediante o uso de um ou mais oligonucleotídeos bloqueadores e kits para a preparação de biblioteca baseada em rna-seq | |
| BR112021024810A2 (pt) | Composto, composição farmacêutica, uso de um composto, método para o tratamento ou profilaxia de câncer e método para o tratamento ou profilaxia de câncer de pulmão de células não pequenas | |
| NO20081907L (no) | Forsinkede hydrokarbongelfornettere og fremgangsmater for fremstilling og anvendelse av disse | |
| JOP20230272A1 (ar) | مركبات تثبيط rip1 وطرق لتحضير واستخدامها | |
| WO2024039901A3 (en) | Cdk2 degraders and uses thereof | |
| WO2020243415A3 (en) | Tead inhibitors and uses thereof | |
| ECSP099027A (es) | Anticuerpos anti-dll4 y métodos que los usan | |
| BR112022011827A2 (pt) | Composto, composição farmacêutica, uso de um composto, métodos para tratamento ou profilaxia de câncer e para tratar um paciente com um distúrbio mediado por receptor do fator de crescimento epidérmico, e, invenção | |
| CL2021000028A1 (es) | Anticuerpo multiespecifico (divisional de solicitud 937-2020). | |
| MY209123A (en) | Compositions, methods and systems for protein corona analysis and uses thereof | |
| PH12023500023A1 (en) | Cdk2 degraders and uses thereof | |
| ZA202204284B (en) | Inhibitors of raf kinases | |
| BR112021023824A8 (pt) | Composto, composição farmacêutica, método para inibir dna-pk e uso do composto ou da composição farmacêutica | |
| BR112022000503A2 (pt) | Compostos úteis para tratar infecções por vírus influenza | |
| GT201000088A (es) | 2 -fluoro-2´desoxitetrahidrouridinas como inhibidores de citidina desaminasa | |
| BRPI0617162B8 (pt) | compostos inibidores de fosfatidilinositol 3-quinase composições farmacêuticas que os contem e métodos de uso dos mesmos | |
| BR112012008624A2 (pt) | inibidores de tirosina quinase de bruton | |
| BRPI0815564B8 (pt) | anticorpos que inibem a dimerização de c-met e usos dos mesmos, hibridoma de murino, anticorpo, ácido nucleico isolado, vetor, método para produção de anticorpo, composição, uso e método de diagnóstico in vitro de enfermidades induzidas por uma superexpressão ou subexpressão do receptor de c-met | |
| MX2022003212A (es) | Anticuerpos anti-klk7, anticuerpos anti-klk5, anticuerpos multiespecificos anti-klk5/klk7 y metodos de uso. | |
| NO20080246L (no) | Anti-IGF1R-antistofformuleringer | |
| CL2009000559A1 (es) | Composicion farmaceutica que comprende trastuzumab-mcc-dm1 y un agente quimioterapeutico seleccionado de un anticuerpo inhibidor de la dimerizacion de her2, un anticuerpo anti-vegf, 5-fu, carboplatino, lapatinib, abt-869, docetaxel, gdc-0941 y gne-390; y su uso para el tratamiento de un trastorno hiperproliferante. | |
| BR112021023024A2 (pt) | Anticorpo contra claudina 18a2 e uso do mesmo | |
| EA200971051A1 (ru) | Ингибиторы p70 s6 киназы | |
| MX2023004869A (es) | Anticuerpos contra sars-cov-2 y usos de los mismos. | |
| BRPI0903359B8 (pt) | composição farmacêutica de metformina, ácido acetilsalicílico e composto de serotonina para o tratamento do câncer |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B11A | Dismissal acc. art.33 of ipl - examination not requested within 36 months of filing | ||
| B11Y | Definitive dismissal - extension of time limit for request of examination expired [chapter 11.1.1 patent gazette] |